Neuralstem, Inc. (NASDAQ:CUR) saw unusually-strong trading volume on Thursday . Approximately 2,551,417 shares were traded during mid-day trading, an increase of 321% from the previous session’s volume of 606,565 shares.The stock last traded at $2.08 and had previously closed at $2.08.
Separately, S&P Equity Research decreased their target price on Neuralstem from $2.26 to $1.91 in a research report on Thursday.
The company has a market capitalization of $31.50, a PE ratio of -1.25 and a beta of 1.60.
Neuralstem, Inc (Neuralstem) is a clinical-stage biopharmaceutical company. The Company is engaged in research, development and commercialization of central nervous system therapies based on its human neuronal stem cells and its stem-cell derived small molecule compounds. The Company has approximately three assets: its NSI-189 small molecule program, its NSI-566 stem cell therapy program and its chemical entity screening platform.
Receive News & Ratings for Neuralstem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neuralstem and related companies with MarketBeat.com's FREE daily email newsletter.